Castle Creek Biosciencesincis A Late Stage Biotechnology Company Based In Extonpennsylvaniait Specializes In Developing And Commercializing Personalized Gene Therapiesparticularly For Severe Genetic Diseasesas A Portfolio Company Of Paragon Biosciencescastle Creek Is Committed To Advancing Innovative Treatments That Improve The Lives Of Patients And Their Families The Company S Lead Product Candidated Fiis Currently In A Registrational Clinical Trial Aimed At Treating Dystrophic Epidermolysis Bullosadeb A Genetic Disorder That Causes Fragile Skin And Severe Blisteringcastle Creek Employs Autologous Fibroblast Therapieswhich Utilize The Patient S Own Cells For Personalized Treatmentthe Company Collaborates With Organizations Such As The Dystrophic Epidermolysis Bullosa Research Association Of America And The Eb Research Partnership To Further Its Mission Of Addressing The Needs Of Those Affected By Deb And Other Genetic Conditions
